Proteome Sciences Plc Stock Performance
| PMSNF Stock | USD 0.04 0.03 300.00% |
Proteome Sciences holds a performance score of 6 on a scale of zero to a hundred. The company holds a Beta of -0.52, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Proteome Sciences are expected to decrease at a much lower rate. During the bear market, Proteome Sciences is likely to outperform the market. Use Proteome Sciences jensen alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to analyze future returns on Proteome Sciences.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Proteome Sciences plc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Proteome Sciences reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 2.2 M | |
| Total Cashflows From Investing Activities | -204 K |
Proteome |
Proteome Sciences Relative Risk vs. Return Landscape
If you would invest 5.00 in Proteome Sciences plc on October 3, 2025 and sell it today you would lose (1.00) from holding Proteome Sciences plc or give up 20.0% of portfolio value over 90 days. Proteome Sciences plc is currently producing 3.1183% returns and takes up 39.5552% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Proteome, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Proteome Sciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Proteome Sciences' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Proteome Sciences plc, and traders can use it to determine the average amount a Proteome Sciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0788
| Best Portfolio | Best Equity | |||
| Good Returns | PMSNF | |||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Proteome Sciences is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Proteome Sciences by adding it to a well-diversified portfolio.
Proteome Sciences Fundamentals Growth
Proteome Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Proteome Sciences, and Proteome Sciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Proteome Pink Sheet performance.
| Return On Asset | 0.06 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 25.13 M | |||
| Shares Outstanding | 295.18 M | |||
| Price To Earning | 50.00 X | |||
| Price To Sales | 2.31 X | |||
| Revenue | 5.13 M | |||
| EBITDA | 625 K | |||
| Cash And Equivalents | 3.2 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 11.68 M | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | 793 K | |||
| Total Asset | 10.04 M | |||
| Retained Earnings | (68 M) | |||
| Current Asset | 2 M | |||
| Current Liabilities | 9 M | |||
About Proteome Sciences Performance
By analyzing Proteome Sciences' fundamental ratios, stakeholders can gain valuable insights into Proteome Sciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Proteome Sciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Proteome Sciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company was incorporated in 1993 and is based in Cobham, the United Kingdom. Proteome Sciences operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 27 people.Things to note about Proteome Sciences plc performance evaluation
Checking the ongoing alerts about Proteome Sciences for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Proteome Sciences plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Proteome Sciences is way too risky over 90 days horizon | |
| Proteome Sciences has some characteristics of a very speculative penny stock | |
| Proteome Sciences appears to be risky and price may revert if volatility continues | |
| Proteome Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Proteome Sciences plc has accumulated 11.68 M in total debt. Proteome Sciences plc has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Proteome Sciences until it has trouble settling it off, either with new capital or with free cash flow. So, Proteome Sciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Proteome Sciences plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Proteome to invest in growth at high rates of return. When we think about Proteome Sciences' use of debt, we should always consider it together with cash and equity. | |
| About 21.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Proteome Sciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Proteome Sciences' stock is overvalued or undervalued compared to its peers.
- Examining Proteome Sciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Proteome Sciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Proteome Sciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Proteome Sciences' pink sheet. These opinions can provide insight into Proteome Sciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Proteome Pink Sheet analysis
When running Proteome Sciences' price analysis, check to measure Proteome Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proteome Sciences is operating at the current time. Most of Proteome Sciences' value examination focuses on studying past and present price action to predict the probability of Proteome Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proteome Sciences' price. Additionally, you may evaluate how the addition of Proteome Sciences to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |